Carlsmed (CARL) Non-Current Debt (2024 - 2026)

Carlsmed (CARL) has reported Non-Current Debt for 3 consecutive years, with $15.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Debt changed 0.32% year-over-year to $15.4 million; the trailing twelve-month figure through Jun 2026 stood at $15.4 million (changed 0.32% YoY), and the FY2025 full-year result was $15.3 million, changed 0.44% from the prior year.
• Non-Current Debt was little changed at $15.4 million in Q2 2026 per CARL's latest filing, from $15.4 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $15.4 million in Q3 2025 and bottomed at $15.3 million in Q4 2025.
• Historically, Non-Current Debt has averaged $15.4 million across 3 years, with a median of $15.4 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Non-Current Debt fell 0.44% in 2025, then fell 0.32% in 2026.
• Over 3 years, Non-Current Debt stood at $15.4 million in 2024, then slipped by 0.44% to $15.3 million in 2025, then gained by 0.23% to $15.4 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $15.4 million, $15.4 million, and $15.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.